Skip to main content
SpringerLink
Log in

Alopecia areata universalis unter Immun-Checkpoint-Blockade bei metastasiertem Melanom

Alopecia areata universalis under immune checkpoint blockade for metastasized melanoma

  • Diaklinik
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Abbreviations

AA:

Alopecia areata

CTLA4:

„Cytotoxic T-lymphocyte-associated Protein 4“

PD-1:

„Programmed cell death 1“

PD-L1:

„Programmed cell death ligand 1“

VEGF:

„Vascular endothelial growth factor“

Literatur

  1. Bergner T, Donhauser G, Ruzicka T (1992) Red lunulae in severe alopecia areata. Acta Derm Venereol 72:203–205

    PubMed  CAS  Google Scholar 

  2. Chelidze K, Lipner SR (2018) Nail changes in alopecia areata: an update and review. Int J Dermatol. https://doi.org/10.1111/ijd.13866

    Article  PubMed  Google Scholar 

  3. Plewig G, Landthaler M, Burgdorf W, Hertl M, Ruzicka Th (2012) Braun-Falco’s Dermatologie, Venerologie und Allergologie. Springer, Berlin, Heidelberg

    Book  Google Scholar 

  4. Strazzulla LC, Wang EHC, Avila L et al (2018) Alopecia areata: An appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol 78:15–24

    Article  PubMed  Google Scholar 

  5. Strazzulla LC, Wang EHC, Avila L et al (2018) Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 78:1–12

    Article  PubMed  Google Scholar 

  6. Wolff H, Fischer TW, Blume-Peytavi U (2016) The Diagnosis and Treatment of Hair and Scalp Diseases. Dtsch Arztebl Int 113:377–386

    PubMed  PubMed Central  Google Scholar 

  7. Zarbo A, Belum VR, Sibaud V et al (2017) Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors. Br J Dermatol 176:1649–1652

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, Frauenlobstraße 9–11, 80337, München, Deutschland

    Anne-Charlotte Niesert, Ilana Goldscheider, Hans Wolff & Carola Berking

Authors
  1. Anne-Charlotte Niesert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilana Goldscheider
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Wolff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carola Berking
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne-Charlotte Niesert.

Ethics declarations

Interessenkonflikt

A.-C. Niesert, I. Goldscheider, H. Wolff und C. Berking geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Alle Patienten, die über Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Fall von nichtmündigen Patienten liegt die Einwilligung eines Erziehungsberechtigten oder des gesetzlich bestellten Betreuers vor.

This article is part of a supplement sponsored by LEO Pharma GmbH.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Niesert, AC., Goldscheider, I., Wolff, H. et al. Alopecia areata universalis unter Immun-Checkpoint-Blockade bei metastasiertem Melanom. Hautarzt 69 (Suppl 1), 62–64 (2018). https://doi.org/10.1007/s00105-018-4194-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-018-4194-6

Search

Navigation